Fifth Lane Capital, LP’s Nektar Therapeutics Position
Does Fifth Lane Capital, LP own Nektar Therapeutics (NKTR)? Yes — 12.0K shares worth $863,400 (+1.05% of its 13F portfolio) as of Q1 2026, up from 4.5K shares the prior filed quarter.
Position Value
$863,400
Q1 2026
Shares
12.0K
% of Portfolio
+1.05%
Quarters Held
2
currently held
Position History NKTR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fifth Lane Capital, LP’s full portfolio or all institutional holders of NKTR.